News

In a day with plenty of quarterly reports, 29Metals Ltd (ASX:29M) has caught eyes on the HotCopper forums after a “more ...
Chicago home rental company Kairos Living continues its expansion within the South Haven development in Denham Springs with ...
Kairos Pharma (NYSE American: KAPA) , a clinical-stage biopharma company advancing cancer therapeutics, will participate in the H.C. Wainwright 27th ...
Carotuximab plus Erleada proved safe in the first 10 patients with metastatic castration-resistant prostate cancer dosed on ...
Affiliates of Harbor Group International LLC (HGI) have provided a $38.3 million loan for the refinancing of a 12-story office building located at 1250 Eye St. in Washington, D.C.’s East End district.
Kairos Pharma, Ltd. (NYSE American:KAPA), a clinical-stage biopharmaceutical company focused on innovative cancer therapeutics, today announces participation and presentation at the H.C. Wainwright ...
Explore more
The long-gestating rules outlining what can be built where in the core of downtown Boston will get at least another few weeks ...
A landmark event in the Philippine energy sector took place as the Institute for Climate and Sustainable Cities (ICSC) ...
Kairos Investment Management Co. purchased the 1980s-era building at the end of 2023 for athird of its prior sale price.
Kairos Investment Management landed a $38.3 million senior loan from Harbor Group International (HGI) for 1250 I Street NW, a ...
Kairos Pharma reported strong safety results from a Phase 2 trial of ENV-105 in mCRPC, with no serious toxicities seen in the ...
Kairos Pharma shares were higher as the company reported positive safety results from a clinical trial of ENV-105, or carotuximab, in patients with metastatic castration-resistant prostate cancer.